An Analysis Finds Shingrix is Highly Effective for Preventing Shingles in Seniors

Shingrix Effectiveness in Preventing Shingles in Seniors

A real-world analysis reveals that Shingrix is highly effective in preventing shingles in adults over 65, including those with compromised immune systems.

Shingles is a viral infection caused by the reactivation of the varicella-zoster virus (VZV), which also causes chickenpox. It commonly affects adults over 50, according to the CDC, and presents as a rash with painful blisters.

Between 5% and 30% of patients with shingles experience post-herpetic neuralgia (PHN), a long-lasting nerve pain. Shingrix, a recombinant zoster vaccine (RZV) manufactured by GSK, provides better protection with two doses than with one.

Two doses of Shingrix provide better protection than one, making it an effective preventive measure for shingles in seniors.

Author's summary: Shingrix prevents shingles effectively.

more

Managed Healthcare Executive Managed Healthcare Executive — 2025-10-14

More News